Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Cathepsin B and L inhibitors described by Nippon Chemiphar

Dec. 3, 1996

Patent issued for method of diagnosing and treating impotence

Dec. 2, 1996

Antihyperlipidemic agents from natural source described by Takeda

Dec. 2, 1996

Potent ACAT inhibitor discovered by Kitasato Institute

Dec. 2, 1996

Lilly research into antiobesity proteins continues

Dec. 2, 1996

Avigen reports successful gene therapy with EPO

Nov. 29, 1996

Harvard Scientific seeks to proceed with clinical trials on erectile dysfunction Rx

Nov. 29, 1996

Animal model for testing osteoporotic therapies available for licensing

Nov. 29, 1996

rhBMP-2 cleared for limited clinical trial for spine fusion

Nov. 28, 1996

FDA clears treatment for bulimia

Nov. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...